In order to analyse the relationships between regulation of apoptosis and homologous recombination (HR), we overexpressed proapoptotic Bax or only-BH3 Bid proteins or antiapoptotic Bcl-2 or Bcl-XL, in hamster CHO cells or in SV40-transformed human fibroblasts. We measured HR induced by c-rays, UVC or a specific double-strand cleavage targeted in the recombination substrate by the meganuclease I-SceI. We show here that the induction of both recombinant cells and recombinant colonies was impaired when expressing Bcl-2 family members, in hamster as well as in human cells. Moreover, the pro-as well as antiapoptotic Bcl-2 family members inhibited HR, independently of degradation of the RAD51 recombination protein and of their impact on apoptosis. These data reveal a mechanism of HR downregulation by potentially proapoptotic proteins, distinct from and parallel to degradation of recombination proteins, a situation that should also optimize the efficiency of programmed cell death.
Introduction
Faithful genome transmission requires the coordination of a network of pathways including cell cycle checkpoint, DNA repair/recombination, and programmed cell death. This network prevents the proliferation of cells bearing genetic alterations. A defect in one of these pathways can lead to tumorigenesis. In this general view, apoptosis is activated following signaling of the DNA damage. However, in a reverse way, antiapoptotic proteins, such as Bcl-2 or Bcl-XL, can also regulate DNA repair. They have been shown to attenuate nucleotide excision repair (NER) (Liu et al., 1997) , to affect the base excision repair (BER) of oxidative damage (Kuo et al., 1999) , mismatch repair (MMR) (Youn et al., 2005) and homologous recombination (HR) repair (Saintigny et al., 2001) . NER, BER, MMR and HR are all error-free DNA repair systems maintaining genome stability (Friedberg et al., 1995) . Decreased efficiency of error-free repair system associated with increased survival should result in viable cells bearing genetic alterations. Indeed, Bcl-2 expression leads to high level of mutagenesis induced by a wide variety of genotoxic stresses (Cherbonnel-Lasserre et al., 1996; Kuo et al., 1999; Saintigny et al., 2001) . Thus, the impact of Bcl-2 is not specific of one type of DNA damage and one DNA repair system and appears therefore to affect general genome stability maintenance: overexpression of Bcl-2 enhances survival but at the cost of genetic stability. This association of responses is reminiscent of the consequences of SOS response in prokaryotes (Radman, 1975) and could be responsible for tumorigenesis. In parallel, the proapoptotic protein Bid has recently been shown to exercise an additional role: regulation of cell cycle checkpoint upon phosphorylation by ATM in response to DNA damages (Kamer et al., 2005; Zinkel et al., 2005) .
The Bcl-2 protein family contains both antiapoptotic proteins, which repress apoptosis, and proapoptotic proteins, which stimulate apoptosis. Modulation of stoichiometric equilibrium between the different family members might control apoptosis regulation. One hypothesis could be that Bcl-2 family members equilibrium also control DNA repair regulation. In agreement with this hypothesis, whereas overexpression of Bcl-2 attenuates NER (Liu et al., 1997) , symmetrically, it is also attenuated in Bax-deficient cells (Cho et al., 2002) . On the other hand, some DNA repair proteins are degraded by caspase, following apoptosis induction, thus optimizing cell death (Lazebnik et al., 1994; Han et al., 1996; Song et al., 1996; Flygare et al., 1998; Huang et al., 1999; Smith et al., 1999) . Degradation of Rad51 (Flygare et al., 1998; Huang et al., 1999) , a protein that plays a pivotal role in gene conversion (Lambert and Lopez, 2000) , should lead to HR inhibition. However, we have previously shown that antiapoptotic proteins Bcl-2 and Bcl-XL also repress HR in mouse L cells and in hamster CHO cells, independently of apoptosis and cell cycle regulation (Saintigny et al., 2001) . Consequently, we address here the question as to whether proapoptotic Bcl-2 family members can also modulate HR, in a mechanism dependent on or independent of apoptosis regulation. Consequently, the latter process would constitute an additional way of inhibiting DNA repair, parallel to caspase degradation. In addition, the fact that the proapoptotic protein Bid can participate to the ATM-dependant cell cycle checkpoint regulation in response to IR (Kamer et al., 2005; Zinkel et al., 2005) also raises the question of the potential impact of Bid on HR regulation.
In the present work, we overexpressed proapoptotic Bax or Bid proteins or the antiapoptotic Bcl-2 or Bcl-XL proteins either in hamster CHO cells or in SV40-transformed human fibroblasts, and we measured HR induced by ionizing radiation (IR), UVC or by targeting a specific cleavage in the recombination substrate, using the I-SceI meganuclease. Inhibition of HR by Bcl-2 or Bcl-XL in hamster CHO or mouse L cells has previously been described (Saintigny et al., 2001) . However, these observations have been challenged by the description of HR stimulation by Bcl-XL overexpression in the human B-cell line TK6 (Wiese et al., 2002) . Species differences (human vs rodent) and/or substrate differences could account for the observed discrepancies. The study in human TK6 cells used an EGFP duplication as reporter system to measure recombinant cells. In rodent cells, we used HR substrate leading to resistance (G418 in CHO cells and HAT in mouse L cells), and monitoring resistant colonies. These two kinds of HR measurement may give different results. For example, the frequency of recombinant cells is not affected, whereas the frequency of recombinant colonies is drastically reduced in cells from Werner syndrome (WS) patients. Indeed, initiation of HR is not affected but viability of recombinant cells is compromised in WS cells (Saintigny et al., 2002) . A similar hypothesis might be advanced here, especially with proteins regulating cell viability such as Bcl-2 family members. Thus, we used CHO cells containing HR substrate which monitor G418-resistant recombinant colonies, identical to that used in our previous work (Saintigny et al., 2001 ) and human SV40-transformed fibroblasts containing the same EGFPbased substrate as that used in TK6 cells (Wiese et al., 2002) . We compared the impact of Bcl-2 family members on both recombinant colonies (G418 resistance) and recombinant cells (EGFP positive), in rodent (CHO cells) and in human (SV40 fibroblasts) cells.
Our results show that the antiapoptotic proteins Bcl-2 and Bcl-XL, as well as the proapoptotic Bax and the only-BH3 Bid, repress HR (both recombinant colonies and recombinant cells) in hamster and human cells. HR repression occurs irrespective of whether the transgenes inhibit or stimulate apoptosis, or are neutral, independently of RAD51 degradation. These data reveal a mechanism distinct from and parallel to degradation of recombination proteins by caspase 3, during which proapoptotic proteins can downregulate HR, a situation which should sensitize cells and thus should also optimize the efficiency of programmed cell death.
Results

Cell lines and HR measurement strategies
Two parental cell lines, containing substrate to measure intrachromosomal HR, were used. The first cell line is derived from Chinese hamster ovary cells (CHO-K1). This line containing a unique intrachromosomal copy of an HR-measuring substrate (Figure 1a ) is named CHO-DRA10 (Liang et al., 1998) . The HR substrate is made of tandem repeats of two inactive copies of the neomycin-resistant gene (resistance to G418 in mammalian cells). Cells are thus sensitive to G418, but HR restores a functional gene (Liang et al., 1998) . HR is estimated by the frequency of G418-resistant colonies arising from viable recombinant cells. The second cell line is the human RG37. This line is derived from the human SV40-transformed fibroblast GM639 in which the pDR-GFP plasmid (Figure 1b) was chromosomally integrated as a single copy and verified by Southern blot (Figure 1b) . The pDR-GFP plasmid contains a tandem repeat of two inactive cassettes coding for EGFP. One of the EGFP cassettes contains one cleavage site for the meganuclease I-SceI. Transient expression of I-SceI allows to target a double-strand break into the chromosomal recombination substrate, which can induce HR. Recombination recreates a functional EGFP. The recombinant cells become fluorescent (Pierce et al., 1999) and can be detected by microscopy or by FACS (Figure 1b) . Importantly, this approach measures recombinant cells.
Expression of the transgenes in CHO cells
After transfection in CHO-DRA10, we established stable puromycin-resistant transfectants expressing either a human HA-tagged-Bax or human His-tagged Bid proteins ( Figure 2 ). Since overexpression of the proapoptotic Bax protein may be toxic, resulting in selection of a subpopulation resistant to chronic Bax overexpression, we also constructed and expressed a Bax protein deleted from the a-helix 9 domain (Da9), homologous to the trans-membrane domain from Bcl-2 protein (Suzuki et al., 2000) . This domain has been shown to be required for mitochondrial targeting of Bax protein (Wolter et al., 1997; Goping et al., 1998) . However, these conclusions have been challenged by data showing that deletion of Da9 did not abolish mitochondrial targeting and cytochrome c release (Tremblais et al., 1999; Heimlich et al., 2004) . Nevertheless, we successfully obtained reliable transfectants stably expressing BaxDa9, in contrast with expression of wild-type Bax (see below).
As controls we also used clones overexpressing two forms of human antiapoptotic Bcl-2 proteins: the Y28A Bcl-2 mutant deficient in both cell cycle regulation and MMR inhibition, but proficient for apoptosis (Huang et al., 1997; Youn et al., 2005) ; and the G145A Bcl-2, deficient in apoptosis repression (Yin et al., 1994) . Both mutant Bcl-2 forms have been shown to inhibit HR in CHO cells (Saintigny et al., 2001) . The different CHO cell lines are listed in Figure 2 .
Immunofluorescence analysis
As suspected, clones expressing the wild-type Bax protein were very heterogeneous, with few cells, among puromycin-resistant clones, actually expressing the exogenous Bax protein (Figure 3a ). This suggests that Bax expression was lost during clone growth. These clones also gave unreliable results for HR analysis (data not shown). We therefore did not use these CHOderived cell lines for further analysis.
In contrast, most cells transfected with BaxDa9 expressed the transgene, with variable intensity (Figure 3a ). Nevertheless, these clones gave reliable results for HR analysis (see below). The two Bcl-2 variants show similar cytoplasmic localization, in part overlapping mitochondrial labeling ( Figure 3b ). The expression was also compatible with ER and nuclear membrane localization. BaxDa9 show a more diffuse but mainly cytoplasmic pattern ( Figure 3b ).
Impact on cell death
Cell death was analysed after induction by TNF-a plus emetine and monitored by nucleus fragmentation monitored by Hoechst fluorescence (Figure 4 ).
Y28A Bcl-2 (ADRA8 cell line) protected three-fold against nuclear fragmentation, whereas G145A Bcl-2 (BDRA1 cell line) did not ( Figure 4 ). Moreover, while Bid (CDRA12 cell line) exhibited no effects, BaxDa9 (XDa9 cell line) stimulated 2.9-fold TNF-a induced cell death (Figure 4 ). These data were confirmed using another method, that is, trypan blue labeling (data not shown).
The different cell lines cover all the possible situations with regard to apoptosis induction, protection ( Y28A Bcl-2), neutral effect ( G145A Bcl-2, Bid) or stimulation (BaxDa9).
HR induced by genotoxic stresses in CHO cells IR has been shown to induce HR in the CHO cells used here (Lambert and Lopez, 2000) , which is inhibited by overexpression of either Y28A Bcl-2 (which represses apoptosis) or G145A Bcl-2 (which does not repress apoptosis) (Saintigny et al., 2001) . Consistent with the apoptosis results, expression of BaxDa9 slightly sensitized cells to IR (Figure 5a 
Inhibition of homologous recombination by BAX or BID
A Dumay et al UV-C has previously been shown to induce HR, which is inhibited by Bcl-2 overexpression in the CHO cells used here (Saintigny et al., 2001; Lambert and Lopez, 2002) . Neither BaxDa9 nor Bid sensitized cells to UV-C (Figure 6a Bcl-2 and HA-tagged BaxDa9. Green: transgenes revealed by immunofluorescence with antibodies anti-Bcl-2 or anti-HA; red: mitochondria staining by Mito-Tracker CMXRos; blue: Hoechst-stained nuclei; lower panel, blue: Endoplasmic reticulum staining by ER-Traker. XDRA: CHO-DRA10 expressing wild-type Bax; ADRA8: CHO-DRA10 expressing Y28A Bcl-2; BDRA1: CHO-DRA10 expressing G145A Bcl-2; XDa9: CHO-DRA10 expressing HA-tagged BaxDa9.
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and Saintigny et al., 2001 ). Particularly, Bid, which is the only-BH3 proapoptotic Bcl-2 family member, repressed HR without affecting apoptosis in the CHO cell line used here. This inhibition is not specific to a type of genotoxic stress since it was observed after g-rays as well as UV-C irradiation, which generate different kinds of DNA damage.
HR induced by one DSB targeted (I-SceI) into the recombination substrate, in human transformed fibroblasts We also used the human RG37 cells to measure the impact of the Bcl-2 family members on HR. The presence of an I-SceI cleavage site allows the targeting of a specific chromosomal double-strand cut, at a precise position in the HR substrate (Pierce et al., 1999) . EGFP as reporter can be used to measure recombinant cells, instead of recombinant colonies with G418 resistance, and thus to measure HR after transient expression of the transgenes, independently of the fate of the recombinant cell; transient expression of wild-type Bax can thus also be tested.
Transient coexpression of the proapoptotic proteins Bax, BaxDa9 or Bid with I-SceI expression plasmid all led to two-to 19-fold repression of HR (Figure 7) . Moreover, in the human cells used here, with the pDR-GFP substrate, we show that the antiapoptotic Bcl-2 and Bcl-XL proteins both inhibit HR from two-to fivefold (Figure 7) , in contrast to the situation in human Bcells (Wiese et al., 2002) . Tissue specificity of the B-cells compared to other tissues, or specificity of the TK6 cell line itself, could also account the differences between the TK6 cells lines and all the other mammalian cell lines. The G145A Bcl-2 mutant, which is defective in apoptosis repression, also inhibits I-SceI-induced HR, independently of apoptosis regulation. Importantly, the Y28A Bcl-2 mutant that fails to repress MMR (Youn et al., 2005) still represses HR, showing that the two repair processes are differently regulated.
Expression of the proapoptotic proteins Bax or Bid did not stimulate degradation of the Rad51 recombination protein In mammalian cells, Rad51 plays a pivotal role in UVC-, g-rays-, and I-SceI-induced HR (Lambert & Lopez, 2000; Lambert & Lopez, 2002) . During g-induced apoptosis, Rad51 protein may be submitted to proteolytic cleavage by caspase 3, leading to a 21 kDa product detectable with RAD51-antibodies (Flygare et al., 1998; Huang et al., 1999) . Since Rad51 can be a limiting factor for HR (Lambert and Lopez, 2000) , one reasonable 
Inhibition of homologous recombination by BAX or BID
A Dumay et al hypothesis could be that Bax or Bid, each of which stimulates apoptosis, induces Rad51 degradation leading in fine to reduction of HR. This hypothesis is challenged by the fact that Bid does not seem to stimulate apoptosis in the cell lines used here. We thus quantified intracellular Rad51 and its potential cleavage product by Western blot after g-irradiation. We used two different doses, 6 and 20 Gy, the former being the physiological dose used here for HR measurement. Expression of BaxDa9 or Bid did not modify the amount of endogenous Rad51 protein and did not result in the production of a proteolytic cleavage product (Figure 8 ). This shows that transgene expression did not substantially affect Rad51 degradation and repress HR in a putative caspase 3-independent pathway. These data are consistent with the fact that Bid represses HR without affecting apoptosis and that antiapoptotic Bcl-2 and Bcl-XL proteins also repress HR, independently of apoptosis regulation.
Discussion
We show here that proapoptotic proteins Bax and Bid impair HR, both recombinant cells and recombinant colonies and in both hamster and human cells. The very controlled apoptosis pathway optimizes cell death by inhibiting DNA repair. Many key DNA repair proteins are cleaved by caspase during programmed cell death (Lazebnik et al., 1994; Han et al., 1996; Song et al., 1996; Flygare et al., 1998; Huang et al., 1999; Smith et al., 1999) . We show here that HR can be repressed in the absence of cleavage by caspase 3 of the pivotal recombination Rad51 protein. Moreover, in the cell lines used here, Bid inhibits HR without affecting apoptosis. Taken together, these results show that in addition to degradation of recombination proteins after apoptosis induction, proapoptotic Bax or potential proapoptotic Bid proteins control complex regulation mechanisms leading to repression of HR, independently of the induction of programmed cell death per se.
We have previously shown that the antiapoptotic Bcl-2 and Bcl-XL proteins inhibit HR in hamster CHO cells or in mouse L cells (Saintigny et al., 2001) . Bcl-2 has also been shown to downregulate MMR genes transcription via the E2F transcription factor, in a cell cycledependent manner, and consequently, the Y28A Bcl-2 mutant, which is deficient in cell cycle regulation, also fails to inhibit MMR (Youn et al., 2005) . In contrast, Y28A Bcl-2 still represses HR (Saintigny et al., 2001 , and present data). Moreover, the endogenous level of Figure 5 Effect of BaxDa9 (a), Bid (b) expression on survival (left panels) after IR and on radiation-induced recombination (right panels). Experiments in (b) were carried out at 4 Gy. The values correspond to the mean of at least three independent experiments. CHO-DRA10: parental line (control); A3: CHO-DRA10 clone transfected with an empty expression vector (control); XDa9 1.7 and XDa9 10.12: two independent CHO-DRA10-derived clones expressing HA-tagged BaxDa9; CDRA 12, 13: two independent clones expressing HIS-tagged Bid. * differences statistically significant (Po0.05) compared to controls (see Materials and methods). Figure 6 Effect of BaxDa9 (a), Bid (b) expression on survival after UV-C (left panels) and on UV-C-induced HR (right panels). The values correspond to the mean of at least three independent experiments. CHO-DRA10: parental line (control); C3: CHO-DRA10 clone transfected with an empty expression vector (control); XDa9 1.7 and XDa9 10.12: two independent CHO-DRA10-derived clones expressing HA-tagged BaxDa9; CDRA 12, 13: two independent clones expressing HIS-tagged Bid. * differences statistically significant (Po0.05) compared to controls (see Materials and methods). 
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Inhibition of homologous recombination by BAX or BID
A Dumay et al RAD51 and RAD54, two recombination proteins under E2F4 control, are not affected by Bcl-2 expression (Saintigny et al., 2001, and unpublished results) . This shows that Bcl-2 affects MMR and HR via distinct pathways. DNA repair is largely dependent on ATM signaling. Since ATM is inactivated during apoptosis , one can ask as whether Bax and bid overexpression could lead to ATM degradation and HR repression. However, high level of HR was measured in cells from Ataxia telangiectasia patients (Meyn, 1993) . In addition, defect in ATM impairs IR-induced Rad51 foci assembly (Yuan et al., 2003) . These data are not consistent with the situation observed here, since Bcl-2 family members expression result in decrease of HR but does not impair Rad51 foci assembly (Saintigny et al., 2001) . Brca1 plays a role in HR (Moynahan et al., 1999) . A p53-dependent feed back loop can modulate Brca1 expression (MacLachlan et al., 2000) . One hypothesis could be that apoptosis regulation might be related to this Brca1 regulation process. However, the cell lines used here are defective for p53 (CHO cells, SV40-transformed fibroblast) and the impact of Bcl-2 on HR has been shown to be independent on p53 status (Saintigny et al., 2001) . Finally, it has been suggested that Bcl2 represses HR, not by changing the transcription level but via post-translation modification of recombination proteins (Saintigny et al., 2001) . The kinase cAbl can control both apoptosis and HR by phosphorylation of Rad51 (Yuan et al., 1998; Kitao and Yuan, 2002) . However, Rad51 foci formation is impaired in c-Abl À/À cells (Yuan et al., 2003) , whereas they are not inhibited by expression of Bcl-2 family members (Saintigny et al., 2001) . On the other hand, the translocation BCR/Abl leads to constitutive activation of Abl and stimulation of HR (Slupianek et al., 2001) .
It is not known as whether pro-and antiapoptotic proteins regulate HR via distinct or common mechanisms. However, one hypothesis could be that perturbation of the steady-state levels and stoichiometric equilibrium between the different Bcl-2 family members might induce one response leading to HR repression.
Remarkably, all the proteins tested contain BH domains: BH1, BH2, BH3 and BH4 for Bcl-2 and Bcl-XL; BH1, BH2, BH3 for Bax and BaxDa9, and only BH3 for Bid. Thus, BH3 is the only domain commonly present in all the transgenes tested here; it is therefore a good candidate for an HR regulation domain among Bcl-2 family members. Associated or not with the presence of the BH3 domain, localization in the membranes could also induce signaling leading to HR repression. Bcl-2 locates to mitochondrial, endoplasmic reticulum membranes and nuclear envelope, and Bcl-XL to the mitochondrial membranes via their transmembrane (TM) domain (Krajewski et al., 1993; Kaufmann et al., 2003) . Bid does not possess one TM domain but can be translocated to the membranes and interact with Bcl-2 or Bax (Zha et al., 2000) . Here, we used a Bax version lacking the a-helix 9. The role of this domain in mitochondrial targeting is controversial (Wolter et al., 1997; Goping et al., 1998; Tremblais et al., 1999; Heimlich et al., 2004) . In the present work, immunocytofluorescence analysis cannot exclude membrane localization of BaxDa9 in the CHO cell line used here. In addition, we show that expression of BaxDa9 stimulates apoptosis, although it is potentially less deleterious than wild-type Bax, since we successfully obtained viable clones stably expressing BaxDa9. Finally, deletion of this domain has been shown to favor translocation of Bax to the mitochondrial membrane in yeast (Priault et al., 2003) . Since all the other proteins tested can be located in the mitochondrial membrane, it is tempting to speculate that overexpression of Bcl-2 family members affects mitochondria membranes resulting in mitochondrial signaling reminiscent of the 'retrograde response' (Butow and Avadhani, 2004) , affecting in fine HR. In line with this, depletion of mitochondrial DNA compromises the respiratory chain function, affects the mitochondrial membrane and results in mutagenesis of nuclear DNA (Delsite et al., 2003) . In the particular case of Bid protein, it has been shown to exhibit a nuclear localization, to be phosphorylated by ATM and required for the ATM-dependent cell cycle checkpoint (Zinkel et al., 2005) ; it could thus affect the ATMdependent regulation of HR. Work is in progress to define the respective impacts of the BH3 domain and of membrane localization on regulation of HR. Thus, whatever the mechanism(s) involved, all Bcl-2 family members tested here repress HR, regardless of their impact on apoptosis, that is, repression (Bcl-2, Bcl-XL), neutral effect ( G145A Bcl-2, Bid in our CHO cell lines) or stimulation (Bax).
Bcl-XL stimulates HR in the human B-cell lineTK6 (Wiese et al., 2002) , in contrast to the inhibition of HR by Bcl-2 or Bcl-XL in hamster CHO-K1 cells or in mouse L cells (Saintigny et al., 2001) . Several hypotheses could explain these differences. TK6 cells are wild type for p53, whereas CHO cells are mutant. However, mouse L cells are wild type for p53 with an efficient G1 checkpoint (Saintigny et al., 1999) , excluding p53 status as an explanation for the discrepancy. Species differences (human vs rodent) are a potential cause, which can also be dismissed since we show here that Bcl-2 also inhibits HR in human SV40-transformed fibroblasts. Another possible explanation is differences in substrates. The study in human TK6 cells used EGFP duplication as reporter system to measure recombinant cells. In rodent cells, we used HR substrate leading to resistance (G418 in CHO cells and HAT in mouse L cells) and monitored resistant colonies. These two kinds of measurement may give different results. Indeed, genetic changes (mutation or overexpression of one protein) may differently affect the occurrence and viability of recombinant cells, as in cells from WS patients, in which initiation of HR is not affected but viability of recombinant cells is compromised (Saintigny et al., 2002) . A similar hypothesis could be advanced with proteins regulating cell viability such as Bcl-2 family members. However, using the same EGFP-based substrate as that used in TK6 cells, we show here that Bcl-2 or Bcl-XL also inhibits the frequency of recombinant cells. Thus, Bcl-2 is able to inhibit HR in hamster, mouse and human cells, acting both on the frequency of recombinant cells and on the frequency of viable recombinant colonies. Tissue specificity of the B-cells compared to other tissues, or specificity of the TK6 cell line itself, could also account for the differences between the TK6 cells lines and all the other mammalian cell lines.
In conclusion, whether the Bcl-2 family members stimulate, are neutral or protect against apoptosis, they all inhibit HR. The consequences of inhibition of an error-free DNA repair system such as HR will depend on the fate of the cell, depending on the associated (but separable) pro-or antiapoptotic character of the overexpressed protein. The antiapoptotic oncogenic Bcl-2, which increases cell survival, inhibits HR, leading to increased genetic instability and so oncogenic potential. On the other hand, the proapoptotic Bax can enhance the efficiency of cell death by inhibiting HR DNA repair. In this case, potential genetic instability due to HR inhibition should not be a problem when proapoptotic proteins are overexpressed since cell survival is highly compromised. Thus, two highly fundamental and symmetrically opposite processes can use a common mechanism (inhibition of HR) to increase their respective efficiencies.
Materials and methods
DNA manipulations
All DNA manipulations were performed as described (Sambrook et al., 1989; Ausubel et al., 1999) .
Y28A
Bcl-2 expression vector was kindly provided by Drs J Adams and S Cory, and is described elsewhere (Huang et al., 1997) .
G145A
Bcl-2 mutant expression vector was kindly provided by Dr SJ Korsmeyer (Yin et al., 1994) . Bid expression vector was kindly provided by Dr S Desagher. Bax expression vector was kindly provided by Dr E May. Deletion of the a-helix 9 domain in BaxDa9 was performed by PCR amplification of the Bax cDNA, using the following oligonucleotides: forward 5 0 ccgctcgagaccatggcttacccatac3 0 and reverse 5 0 ccggtacctcatgtct gccatgtgggggtc3 0 .
Cells
Cell lines were cultured at 371C with 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum (FCS), 2 mM glutamine, 200 IU/ml penicillin, 100 mg/ml streptomycin. The transgene expression vector was pcDNA-puro (Lambert and Lopez, 2000) , containing a puromycin-resistant gene. Stable CHO transfectants were selected with 5 mg/ml of puromycin.
Western blot analysis
All extract preparation steps were performed at 41C. After washing with PBS, cells were suspended in lysis buffer (25 mM Tris pH 7.5, 5 mM EDTA, 600 mM NaCl, 1 mM DTT, 0.1% NP40, 5 mg/ml leupeptin, 2 mM pepstatin, 1 mM PMSF, 10% glycerol) and incubated for 30 min on ice. Extracts were centrifuged for 30 min at 15 000 g, supernatant was retrieved and protein concentration was determined using Biorad Protein Assay (Biorad). In total, 50 mg/well of the boiled samples were loaded on a 10% polyacrylamide gel for electrophoresis (PAGE) in the presence of SDS. After migration, the proteins were electrotransferred onto a nitrocellulose membrane and probed with anti-Bcl-2 (Sc-509 Santa Cruz), anti-Bax (Sc 493 Santa Cruz) or anti-Bid (AF860 R&D Systems). For RAD51 expression, cells were irradiated at 6 or 20 Gy (in PBS using 137Cs irradiator, 1.8 Gy/min) and extracts were performed at 0, 6, 12, 24 h postirradiation. RAD51 was probed with anti-Rad51 (Oncogene Research) and actin with antiactin antibody (Sigma). Standard procedures were used for the electrophoresis, transfer and Western blotting. Antibodies were visualized using the ECL detection kit (Amersham).
Immunofluorescence Cells were grown on glass coverslips. To stain for mitochondria (red), cells were incubated at 371C for 30 min with 100 nM Mito-Tracker CMXRos (Molecular Probes, Inc., Eugene, OR, USA), or for endoplasmic reticulum (ER) staining (blue), with 500 nM ER-Tracker (Molecular Probes, Inc., Eugene, OR, USA) for 30 min. To stain for transgenes, cells were fixed with 3.7% paraformaldehyde for 15 min at room temperature and permeabilized with acetone for 1 min. Cells were incubated 1 h with the primary antibodies diluted in PBS 1% BSA (1/500 mouse anti-HA (Covance CRP, Inc., CA, USA) or 1/500 mouse anti-Bcl-2 (Sc-509 Santa Cruz Biotechnology, Santa Cruz, CA, USA), washed with PBS 1% BSA, then incubated with FITC-conjugated goat anti-mouse Ig (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA), and stained for 5 min with Hoechst 33342. Finally, the slides were mounted in fluorescent mounting medium (citifluor). Transgene and Mito-Tracker images images, by optic microscopy, were overlaid to show colocalisation. Epi-fluorescence under a DMR Leica microscope and DP controller and DP manager (Olympus Optical CO).
Measurement of apoptosis
Cell death was induced by addition of tumor necrosis factor-a (TNF-a, 3.75 ng/ml, Sigma, St Louis, MO, USA) plus emetine (0.75 mg/ml) on exponentially growing adherent cells.
Analysis of nuclear fragmentation (Hoechst fluorescence). At 24 h after treatment, cells were fixed for 15 min with 3.7% PFA, permeabilized for 1 min with acetone, and Hoechststained for 5 min. The cells were visualized by fluorescence microscopy. In contrast to normal cells, the nuclei of apoptotic cells appear to be featureless, bright spherical beads. For each point, at least 500 cells were counted.
Measurement of recombination (A) After g-ray (irradiation in PBS, using a 137 Cs irradiator, 1.8 Gy/min) or UV-C (254 nm at 0.7 J/m 2 /s): After irradiation, cells were incubated in their medium at 371C for 24 h. Cells were then trypsinized, counted and divided into two fractions. The first fraction was used to calculate the viability by cloning efficiency. The second fraction was plated under 1 mg/ml G418 selection to measure recombination frequency. (B) By I-SceI: RG37 cells were co-transfected with 0, or 0.5 mg of HAtaggued-I-SceI expression vector (Liang et al., 1998) and 1.5 mg of transgene (Bcl-2 family members), q.s.p. 2 mg DNA with empty expression vector (pcDNA6, InVitrogen), in each point. Transfections were carried out using JetPEI (Q-Biogen). Recombinant cells were measured by FACS, 72 h after transfection. The efficiency of transfection or cotransfection of HA-tagged-I-SceI was followed using an anti-HA antibody.
Statistical analysis
Results are mean7S.E.M. of at least three independent experiments. Statistical analyses were performed using 
